Spontaneous gross haematuria during dabigatran therapy for secondary stroke prevention

MeSH terms

• Adenocarcinoma / blood
• Adenocarcinoma / drug therapy
• Adenocarcinoma / secondary
• Aged, 80 and over
• Antineoplastic Agents, Hormonal / therapeutic use
• Antithrombins / adverse effects*
• Antithrombins / pharmacokinetics
• Antithrombins / therapeutic use
• Atrial Fibrillation / complications
• Benzimidazoles / adverse effects*
• Benzimidazoles / pharmacokinetics
• Benzimidazoles / therapeutic use
• Bone Neoplasms / blood
• Bone Neoplasms / drug therapy
• Bone Neoplasms / secondary
• Brain Ischemia / etiology
• Brain Ischemia / prevention & control*
• Comorbidity
• Dabigatran
• Hematuria / chemically induced*
• Humans
• Kidney Failure, Chronic / blood
• Kidney Failure, Chronic / complications
• Leuprolide / therapeutic use
• Male
• Prostatic Neoplasms / blood
• Prostatic Neoplasms / drug therapy
• Pulmonary Disease, Chronic Obstructive / blood
• Pulmonary Disease, Chronic Obstructive / complications
• Secondary Prevention
• Thrombophilia / drug therapy*
• Thrombophilia / etiology
• Urinary Retention / chemically induced
• beta-Alanine / adverse effects
• beta-Alanine / analogs & derivatives*
• beta-Alanine / pharmacokinetics
• beta-Alanine / therapeutic use